University of Oxford Featured Masters Courses
Cranfield University Featured Masters Courses
Alexandru Ioan Cuza University of Iasi Featured Masters Courses
King’s College London Featured Masters Courses
FindA University Ltd Featured Masters Courses

Available places: European candidates or non-European candidates residing in Italy: 40; Non-European candidates residing outside Italy: 10 (2 for candidates joining the Marco Polo Project; 2 for the bilateral agreement with Nanjing University)

 Course structure

  • Advanced Reactivity And Modelling
  • Advanced Molecular Biology
  • Molecular And Experimental Pharmacology
  • Structural Biochemistry
  • Bioinformatics And Computational Biology
  • Drug Discovery And Development
  • Pharmaceutical Nanotechnology
  • Protein Engineering
  • Proteomics And Biochemical Methodologies
  • Biologics And Biopharmaceuticals
  • Delivery And Formulation Of Biotechnological Drugs
  • Diagnostic Microbiology And Molecular Immunology

 Course description

The purpose of the Master of Science in Pharmaceutical Biotechnologies (two years, 120 CFU) is to endow students with a sound scientific knowledge for modern pharmaceutical research and health biotechnologies.

The organization and the needs of the research in the pharmaceutical field have changed dramatically in recent years. Modern research in both academic and industrial setting is intensely devoted to the study and development of biopharmaceuticals, including the development of biologics and monoclonal antibodies of new conception. Currently, the pharmaceutical scientist requires a thorough education and expertise in molecular biology, genetics, recombinant DNA techniques and bioinformatics, with a solid background in chemistry, pharmacology and advanced pharmaceutical technology. The professionals working in pharmaceutical R&D and production must possess a sound interdisciplinary knowledge, including the specific technical and regulatory issues dedicated to the research, development and monitoring of innovative drugs and biosimilars.

The Master of Science focuses on “transferring” knowledge, endowing students with strong technical skills (hard skills) and interpersonal skills (soft skills), building at the same time those competencies needed to face the changing pharmaceutical marketplace. Graduates in Pharmaceutical Biotechnologies will acquire a solid knowledge in biochemistry, molecular biology and protein engineering, immunology, pharmacology and pharmaceutical technology, and in those disciplines required to design, analyze and formulate innovative drugs such as biologics and drugs employed in targeted therapies. The knowledge of the physico-chemical properties of molecules and macromolecules enable students to apply the analytical methods required for the identification, purification and characterization of biopharmaceuticals during production and quality control.

Strengths: innovative teaching approach; critical approach to science (not only theory!); students have an active role in organizing events, projects and investigations; excellent Teacher/Students ratio; high student satisfaction score (>8.5/10); high employability rate (90%, in Italy); most students graduate with full marks and pursue a PhD abroad.

 Career opportunities

Graduates in Pharmaceutical Biotechnologies will operate in various areas of academic and industrial research at national and international level. They will be able to tackle problems related to the study and development of drugs and diagnostics and will work in several fields associated with the production and quality control of the pharmaceutical, biopharmaceutical, diagnostic and scientific instrumentation, as well as the cosmetic and nutraceutical industries and those interested in human and animal nutrition.


Visit the Pharmaceutical Biotechnologies page on the University of Padova website for more details!

Loading...

Loading...

Loading...


Enquire About This Course

Recipient: University of Padova

* required field

Please correct the errors indicated below to send your enquiry


Your enquiry has been emailed successfully